Client’s Goals

Our client, a nonprofit biomedical research institute, was keen on building a substantive business from in-vivo toxicology testing services in North America and Europe. We offered in-depth intelligence into the interconnected ecosystem and adjacent markets of client’s clients and their clients. For this purpose, we have solved a defined a series of problems and helped in the identification of latent opportunities. Few of the key problems solved during our engagement with the client are:

• Insights into in-vivo toxicology services and end-use industries to prioritize
• County-level regional insights in Europe and North America for prioritization
• Understanding of the service costs for different tests in the in-vivo toxicology market

Our Approach

We started by identifying key areas where laboratories need to undertake in-vivo toxicology testing services for immunotoxicity, systemic toxicity, genotoxicity, and other toxicity services in the European and North American countries. Our analysts also helped the client understand the market for all the segments, along with all the subsegments through access to our AI-driven market intelligence platform, KnowledgeStore. We also interviewed a host of potential customers in these industries to understand their unmet needs, possible use cases, and acquire information on pricing.

Our team offered insights into the market potential and cost analysis of testing services such as immunotoxicity, systemic toxicity, genotoxicity, and other toxicity services across these end-use industries. Further, we helped the client to expand the understanding of each of the in-vivo testing services. With the help of our client services team, the client devised a differentiated product offering and forged suitable alliances to help them win in this market.

Revenue Shifts Identified

High research and development expenditure, mandatory government regulations for animal testing, growing research and development activities in biomedicine is on rise. These factors are further augmented by growth in the biosimilars & generics market and increasing preclinical activities in CROs and pharmaceutical companies.

Interconnections

Increasing focus on predictive toxicology is expected to further contribute to the development of predictive toxicology assays and models which has become
a primary concern for drug makers.

Unknowns Identified

Increasing research in oncology for drug discovery and personalized medicine and the rising demand for humanized animal models are few emerging areas those are expected to offer opportunities for the testing services.

Revenue Impact (RI)

Our insights helped in identifying ~USD 15 million worth new revenue opportunities by tapping into the in-vivo toxicology testing services market across North America and Europe.